Tectonic Therapeutic TECX
NASDAQ TECX
$23.29 -0.05 (-0.21%)
At close: Sep 30, 2026 · 4:00 PM EDT

Tectonic Therapeutic (TECX) Liabilities and Shareholders Equity (2017 - 2026)

Updated

Tectonic Therapeutic (TECX) posted Liabilities and Shareholders Equity of $237.03 million for Q2 2026, down 19.7% from $295.31 million a year earlier and down 3.9% from the prior quarter.

Analysis

Tectonic Therapeutic (TECX) Liabilities and Shareholders Equity (2017 - 2026) Analysis & Trends

At the end of FY2025, Tectonic Therapeutic's Liabilities and Shareholders Equity came in at $261.04 million, up 70.7% from FY2024.

  • Annual Liabilities and Shareholders Equity shows a five-year compound annual growth rate of -0.8% (FY2020 to FY2025).
  • In prior years, Tectonic Therapeutic's Liabilities and Shareholders Equity was $152.91 million in FY2024 (+288.1%), $39.4 million in FY2023 (-62.1%), $103.95 million in FY2022 (-49.0%) and $203.84 million in FY2021 (-24.8%).
  • The Q2 2026 figure stands as the lowest quarterly Liabilities and Shareholders Equity since Q4 2024.
  • On a year-over-year basis, Liabilities and Shareholders Equity increased in six of the last eight quarters, with growth averaging 90.9%.
  • The strongest year-over-year quarter for Liabilities and Shareholders Equity in the past five years was Q4 2024, with growth of 288.1%; the weakest was Q4 2023, with a decline of 62.1%.
  • According to Business Quant data, Liabilities and Shareholders Equity for the three prior quarters was $246.58 million (Q1 2026), $261.04 million (Q4 2025) and $277 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Liabilities and Shareholders Equity (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 201.06 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 135.12 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 129.80 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn 122.03 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 115.83 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 95.64 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 49.36 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 201.13 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 27.42 Bn
10 Tectonic Therapeutic 447.99 Mn 447.99 Mn - 237.03 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 237.03 Mn
Mar 31, 2026 246.58 Mn
Dec 31, 2025 261.04 Mn
Sep 30, 2025 277.00 Mn
Jun 30, 2025 295.31 Mn
Mar 31, 2025 314.83 Mn
Dec 31, 2024 152.91 Mn
Sep 30, 2024 168.72 Mn
Jun 30, 2024 193.91 Mn
Mar 31, 2024 92.35 Mn
Dec 31, 2023 39.40 Mn
Sep 30, 2023 110.52 Mn
Jun 30, 2023 133.84 Mn
Mar 31, 2023 83.01 Mn
Dec 31, 2022 103.95 Mn
Sep 30, 2022 129.50 Mn
Jun 30, 2022 146.24 Mn
Mar 31, 2022 175.34 Mn
Dec 31, 2021 203.84 Mn
Sep 30, 2021 216.45 Mn
API Access

Tectonic Therapeutic Liabilities and Shareholders Equity API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=liabilities-and-shareholders-equity&ticker=TECX&period=max&api_key=YOUR_API_KEY